X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (119) 119
index medicus (100) 100
humans (89) 89
colorectal cancer (51) 51
female (48) 48
male (45) 45
aged (44) 44
chemotherapy (44) 44
middle aged (42) 42
colorectal neoplasms - drug therapy (37) 37
antineoplastic combined chemotherapy protocols - therapeutic use (32) 32
cancer (32) 32
oxaliplatin (30) 30
adult (29) 29
colorectal neoplasms - pathology (24) 24
fluorouracil (24) 24
treatment outcome (24) 24
leucovorin (23) 23
cetuximab (22) 22
disease-free survival (22) 22
metastasis (22) 22
survival (22) 22
aged, 80 and over (21) 21
care and treatment (21) 21
clinical trials (19) 19
fluorouracil - administration & dosage (19) 19
research (19) 19
leucovorin - administration & dosage (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
tumors (17) 17
1st-line treatment (16) 16
drug administration schedule (16) 16
drug therapy (16) 16
analysis (15) 15
colon cancer (15) 15
colorectal neoplasms - mortality (15) 15
5-fluorouracil (14) 14
carcinoma (14) 14
colonic neoplasms - drug therapy (14) 14
irinotecan (14) 14
medicine & public health (14) 14
prognosis (14) 14
bevacizumab (13) 13
cancer therapies (13) 13
organoplatinum compounds - administration & dosage (13) 13
patients (13) 13
adenocarcinoma - drug therapy (12) 12
antineoplastic agents - therapeutic use (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (12) 12
camptothecin - analogs & derivatives (12) 12
colorectal neoplasms - genetics (12) 12
hematology, oncology and palliative medicine (12) 12
neoplasm metastasis (12) 12
neoplasm staging (12) 12
phase-iii trial (12) 12
therapy (12) 12
animals (11) 11
camptothecin - administration & dosage (11) 11
colorectal carcinoma (11) 11
mutation (11) 11
survival rate (11) 11
adjuvant treatment (10) 10
cancer patients (10) 10
chemotherapy, adjuvant (10) 10
combination (10) 10
kaplan-meier estimate (10) 10
surgery (10) 10
survival analysis (10) 10
time factors (10) 10
trial (10) 10
colon (9) 9
colonic neoplasms - pathology (9) 9
metastases (9) 9
phase-ii (9) 9
antibodies, monoclonal - administration & dosage (8) 8
fluorouracil - adverse effects (8) 8
history (8) 8
immunohistochemistry (8) 8
italian language (8) 8
liver metastases (8) 8
patient outcomes (8) 8
randomized controlled trials as topic (8) 8
risk factors (8) 8
antibodies, monoclonal, humanized (7) 7
capecitabine (7) 7
drug resistance (7) 7
fluorouracil - therapeutic use (7) 7
folinic acid (7) 7
leucovorin - adverse effects (7) 7
metastatic colorectal cancer (7) 7
predictive value of tests (7) 7
review (7) 7
solid tumors (7) 7
toxicity (7) 7
advanced colorectal-cancer (6) 6
antineoplastic agents (6) 6
antineoplastic agents - adverse effects (6) 6
colorectal neoplasms (6) 6
colorectal neoplasms - metabolism (6) 6
efficacy (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (11) 11
UTL at Downsview - May be requested (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2018, Volume 378, Issue 13, pp. 1177 - 1188
This analysis involving patients with stage III colon cancer pooled the findings of six clinical trials regarding the effect of adjuvant-therapy duration on... 
SURVIVAL | MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | BEVACIZUMAB | PHASE-III | OXALIPLATIN | FLUOROURACIL | Capecitabine - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Young Adult | Clinical Trials, Phase III as Topic | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Oxaliplatin | Fluorouracil - adverse effects | Aged, 80 and over | Adult | Female | Chemotherapy, Adjuvant | Drug Administration Schedule | Neoplasm Recurrence, Local | Proportional Hazards Models | Randomized Controlled Trials as Topic | Disease-Free Survival | Medication Adherence | Capecitabine - adverse effects | Colonic Neoplasms - pathology | Intention to Treat Analysis | Nervous System Diseases - chemically induced | Aged | Neoplasm Staging | Organoplatinum Compounds - adverse effects | Care and treatment | Usage | Colon cancer | Adjuvant treatment | Clinical trials | Research | Comparative analysis | Cancer | Colorectal cancer | Event-related potentials | Oncology | Population studies | Cancer therapies | Survival | Patients | Confidence intervals | Neurotoxicity | Chemotherapy | Hospitals | Collaboration | Colon | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 31, pp. 4706 - 4713
Panitumumab is a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody that improves progression-free survival (PFS) in... 
SURVIVAL | 1ST-LINE TREATMENT | CONTROLLED-TRIAL | SUPPORTIVE CARE | ONCOLOGY | CETUXIMAB PLUS IRINOTECAN | KRAS | OXALIPLATIN | FAILURE | CHEMOTHERAPY | Leucovorin - administration & dosage | Predictive Value of Tests | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Chemotherapy, Adjuvant | Colorectal Neoplasms - metabolism | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Drug Administration Schedule | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Neoplasm Staging | Index Medicus
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 14, pp. 2311 - 2319
Journal Article
Clinical cancer research, ISSN 1078-0432, 2015, Volume 21, Issue 24, pp. 5469 - 5479
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 503 - 503
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 677 - 677
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. 3599 - 3599
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 06/2013, Volume 31, Issue 18, pp. LBA4001 - LBA4001
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2017, Volume 35, Issue 4, pp. 757 - 757
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. 3568 - 3568
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 3501 - 3501
Conference Proceeding
European Journal of Cancer, ISSN 0959-8049, 09/2018, Volume 100, pp. 35 - 45
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2016, Volume 34, Issue 4, pp. TPS785 - TPS785
Conference Proceeding
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.